aTYR PHARMA INC — All Filings
722 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
10-Q/A
3
3/A
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS EX
PRE 14A
REGDEX
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| ARS | ARS | 0001339970-26-000023 | Mar 26, 2026 | Dec 31, 2025 |
| DEFA14A | DEFA14A | 0001339970-26-000022 | Mar 26, 2026 | — |
| SCHEDULE 13G/A | — | 0000102909-26-000733 | Mar 26, 2026 | — |
| DEF 14A | DEF 14A | 0001339970-26-000021 | Mar 26, 2026 | — |
| PRE 14A | PRE 14A | 0001339970-26-000012 | Mar 12, 2026 | — |
| 10-K | 10-K | 0001339970-26-000008 | Mar 5, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001339970-26-000006 | Mar 5, 2026 | — |
| 4 | 4 | 0001193125-26-038007 | Feb 4, 2026 | Feb 3, 2026 |
| 4 | 4 | 0001193125-26-038002 | Feb 4, 2026 | Feb 3, 2026 |
| 4 | 4 | 0001193125-26-037996 | Feb 4, 2026 | Feb 3, 2026 |
| 4 | 4 | 0001193125-26-009161 | Jan 9, 2026 | — |
| 4 | 4 | 0001193125-26-009156 | Jan 9, 2026 | — |
| 4 | 4 | 0001193125-26-009152 | Jan 9, 2026 | — |
| 8-K | 8-K | 0001193125-25-309619 | Dec 5, 2025 | Dec 4, 2025 |
| 10-Q | 10-Q | 0001193125-25-269587 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-269486 | Nov 6, 2025 | — |
| 4 | 4 | 0001193125-25-236131 | Oct 9, 2025 | Oct 8, 2025 |
| 8-K | 8-K | 0001193125-25-202865 | Sep 15, 2025 | — |
| EFFECT | — | 9999999995-25-002665 | Aug 18, 2025 | — |
| CORRESP | — | 0001339970-25-000018 | Aug 13, 2025 | — |
| UPLOAD | — | 0000000000-25-008523 | Aug 13, 2025 | — |
| 8-K/A | 8-K/A | 0001339970-25-000016 | Aug 8, 2025 | Aug 7, 2025 |
| S-8 | S-8 | 0001339970-25-000013 | Aug 7, 2025 | — |
| S-3 | S-3 | 0001339970-25-000011 | Aug 7, 2025 | — |
| 10-Q | 10-Q | 0001339970-25-000009 | Aug 7, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001339970-25-000007 | Aug 7, 2025 | — |
| SCHEDULE 13G | — | 0000932471-25-000820 | Jul 29, 2025 | — |
| SCHEDULE 13G | — | 0002052113-25-003144 | Jul 17, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-002378 | May 15, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-065640 | May 7, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0000950170-25-065611 | May 7, 2025 | — |
| 8-K | 8-K | 0000950170-25-064413 | May 6, 2025 | May 1, 2025 |
| 4 | 4 | 0000950170-25-062947 | May 2, 2025 | May 1, 2025 |
| 4 | 4 | 0000950170-25-062945 | May 2, 2025 | May 1, 2025 |
| 4 | 4 | 0000950170-25-062942 | May 2, 2025 | May 1, 2025 |
| 4 | 4 | 0000950170-25-062937 | May 2, 2025 | May 1, 2025 |
| 4 | 4 | 0000950170-25-062935 | May 2, 2025 | May 1, 2025 |
| 4 | 4 | 0000950170-25-062932 | May 2, 2025 | May 1, 2025 |
| ARS | ARS | 0000950170-25-042016 | Mar 19, 2025 | Dec 31, 2024 |
| DEFA14A | DEFA14A | 0000950170-25-042000 | Mar 19, 2025 | — |
| DEF 14A | DEF 14A | 0000950170-25-041992 | Mar 19, 2025 | — |
| 4 | 4 | 0000950170-25-040600 | Mar 17, 2025 | — |
| 10-K | 10-K | 0000950170-25-038888 | Mar 13, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0000950170-25-038703 | Mar 13, 2025 | — |
| 4 | 4 | 0000950170-25-013891 | Feb 4, 2025 | Feb 3, 2025 |
| 4 | 4 | 0000950170-25-013884 | Feb 4, 2025 | Feb 3, 2025 |
| 4 | 4 | 0000950170-25-013878 | Feb 4, 2025 | Feb 3, 2025 |
| 4 | 4 | 0000950170-25-004151 | Jan 10, 2025 | Jan 8, 2025 |
| 4 | 4 | 0000950170-25-004145 | Jan 10, 2025 | Jan 8, 2025 |
| 4 | 4 | 0000950170-25-004131 | Jan 10, 2025 | Jan 8, 2025 |